nodes	percent_of_prediction	percent_of_DWPC	metapath
Vidarabine—DPP4—Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)—PAX6—glaucoma	0.0168	0.0708	CbGpPWpGaD
Vidarabine—ADORA2A—NGF-independant TRKA activation—NTRK2—glaucoma	0.0162	0.0684	CbGpPWpGaD
Vidarabine—ADORA2A—Activation of TRKA receptors—NTRK2—glaucoma	0.014	0.0591	CbGpPWpGaD
Vidarabine—ADORA2A—NGF-independant TRKA activation—NTRK1—glaucoma	0.0132	0.0557	CbGpPWpGaD
Vidarabine—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—PAX6—glaucoma	0.0124	0.0522	CbGpPWpGaD
Vidarabine—ADORA2A—Activation of TRKA receptors—NTRK1—glaucoma	0.0114	0.0482	CbGpPWpGaD
Vidarabine—DPP4—Incretin synthesis, secretion, and inactivation—PAX6—glaucoma	0.011	0.0464	CbGpPWpGaD
Vidarabine—ADORA2A—Activation of TRKA receptors—NGF—glaucoma	0.00929	0.0391	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—ATOH7—glaucoma	0.0089	0.0375	CbGpPWpGaD
Vidarabine—DPP4—Peptide hormone metabolism—ACE2—glaucoma	0.00701	0.0295	CbGpPWpGaD
Vidarabine—ADK—Nucleotide metabolism—TXN—glaucoma	0.00666	0.0281	CbGpPWpGaD
Vidarabine—ADA—C-MYB transcription factor network—CA1—glaucoma	0.00662	0.0279	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—ATOH7—glaucoma	0.00511	0.0215	CbGpPWpGaD
Vidarabine—ADORA2A—Monoamine Transport—SLC6A1—glaucoma	0.00472	0.0199	CbGpPWpGaD
Vidarabine—ADA—Nucleotide metabolism—TXN—glaucoma	0.00452	0.0191	CbGpPWpGaD
Vidarabine—Glucosamine—MMP9—glaucoma	0.00437	0.395	CrCbGaD
Vidarabine—Adenosine triphosphate—ABCA1—glaucoma	0.00383	0.346	CrCbGaD
Vidarabine—DPP4—Peptide hormone metabolism—PAX6—glaucoma	0.00374	0.0158	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—OPN4—glaucoma	0.00354	0.0149	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Other—PTGFR—glaucoma	0.00345	0.0146	CbGpPWpGaD
Vidarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—IL1A—glaucoma	0.00337	0.0142	CbGpPWpGaD
Vidarabine—Glucosamine—TNF—glaucoma	0.00287	0.259	CrCbGaD
Vidarabine—ADA—Validated transcriptional targets of TAp63 isoforms—FAS—glaucoma	0.00269	0.0113	CbGpPWpGaD
Vidarabine—ADA—p73 transcription factor network—NTRK1—glaucoma	0.00253	0.0107	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—DHPS—glaucoma	0.0023	0.00971	CbGpPWpGaD
Vidarabine—ADA—C-MYB transcription factor network—GSTM1—glaucoma	0.00211	0.00888	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—OPN4—glaucoma	0.00203	0.00857	CbGpPWpGaD
Vidarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—glaucoma	0.00202	0.00852	CbGpPWpGaD
Vidarabine—ADA—p73 transcription factor network—FAS—glaucoma	0.00198	0.00836	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CA5A—glaucoma	0.00192	0.0081	CbGpPWpGaD
Vidarabine—ADK—Metabolism—NARFL—glaucoma	0.00192	0.0081	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00182	0.00768	CbGpPWpGaD
Vidarabine—ADA—Validated transcriptional targets of TAp63 isoforms—CDKN2A—glaucoma	0.00181	0.00762	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Other—SMO—glaucoma	0.00174	0.00734	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00167	0.00702	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.0015	0.00632	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—CTSA—glaucoma	0.00144	0.00606	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00143	0.00602	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—ACE2—glaucoma	0.00132	0.00558	CbGpPWpGaD
Vidarabine—ADA—Metabolism—NARFL—glaucoma	0.00131	0.00551	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CA5A—glaucoma	0.00131	0.00551	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00129	0.00542	CbGpPWpGaD
Vidarabine—ADA—C-MYB transcription factor network—CDKN2A—glaucoma	0.00127	0.00535	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—NGFR—glaucoma	0.00126	0.00532	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—NTRK1—glaucoma	0.0012	0.00505	CbGpPWpGaD
Vidarabine—ADA—C-MYB transcription factor network—PTGS2—glaucoma	0.00119	0.005	CbGpPWpGaD
Vidarabine—ADA—C-MYB transcription factor network—CDKN1B—glaucoma	0.00112	0.00474	CbGpPWpGaD
Vidarabine—ADORA2A—HIF-2-alpha transcription factor network—VEGFA—glaucoma	0.00111	0.00467	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—OPN4—glaucoma	0.00109	0.00458	CbGpPWpGaD
Vidarabine—ADORA2A—Monoamine Transport—TNF—glaucoma	0.000996	0.0042	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—PTGFR—glaucoma	0.000979	0.00413	CbGpPWpGaD
Vidarabine—Hypertension—Brinzolamide—glaucoma	0.000954	0.00127	CcSEcCtD
Vidarabine—Anxiety—Dorzolamide—glaucoma	0.000954	0.00127	CcSEcCtD
Vidarabine—Chest pain—Travoprost—glaucoma	0.000953	0.00127	CcSEcCtD
Vidarabine—Cardiac arrest—Timolol—glaucoma	0.000953	0.00127	CcSEcCtD
Vidarabine—Syncope—Pilocarpine—glaucoma	0.000953	0.00127	CcSEcCtD
Vidarabine—Anxiety—Travoprost—glaucoma	0.00095	0.00126	CcSEcCtD
Vidarabine—Mood swings—Timolol—glaucoma	0.000949	0.00126	CcSEcCtD
Vidarabine—Nausea—Carteolol—glaucoma	0.000949	0.00126	CcSEcCtD
Vidarabine—Headache—Levobunolol—glaucoma	0.000946	0.00126	CcSEcCtD
Vidarabine—Discomfort—Dorzolamide—glaucoma	0.000946	0.00126	CcSEcCtD
Vidarabine—Shock—Brimonidine—glaucoma	0.000945	0.00126	CcSEcCtD
Vidarabine—Discomfort—Travoprost—glaucoma	0.000942	0.00125	CcSEcCtD
Vidarabine—Chest pain—Brinzolamide—glaucoma	0.000941	0.00125	CcSEcCtD
Vidarabine—ADA—Circadian rythm related genes—FAS—glaucoma	0.000939	0.00396	CbGpPWpGaD
Vidarabine—Palpitations—Pilocarpine—glaucoma	0.000939	0.00125	CcSEcCtD
Vidarabine—ADK—Metabolism—CA1—glaucoma	0.000938	0.00396	CbGpPWpGaD
Vidarabine—Tachycardia—Brimonidine—glaucoma	0.000938	0.00125	CcSEcCtD
Vidarabine—Dry mouth—Dorzolamide—glaucoma	0.000936	0.00125	CcSEcCtD
Vidarabine—Loss of consciousness—Pilocarpine—glaucoma	0.000934	0.00124	CcSEcCtD
Vidarabine—Nausea—Diclofenamide—glaucoma	0.000933	0.00124	CcSEcCtD
Vidarabine—Dry mouth—Travoprost—glaucoma	0.000932	0.00124	CcSEcCtD
Vidarabine—Acute coronary syndrome—Betaxolol—glaucoma	0.000932	0.00124	CcSEcCtD
Vidarabine—Discomfort—Brinzolamide—glaucoma	0.00093	0.00124	CcSEcCtD
Vidarabine—Pain—Bimatoprost—glaucoma	0.000928	0.00123	CcSEcCtD
Vidarabine—Cough—Pilocarpine—glaucoma	0.000927	0.00123	CcSEcCtD
Vidarabine—Myocardial infarction—Betaxolol—glaucoma	0.000927	0.00123	CcSEcCtD
Vidarabine—Dizziness—Latanoprost—glaucoma	0.000926	0.00123	CcSEcCtD
Vidarabine—Dry mouth—Brinzolamide—glaucoma	0.00092	0.00122	CcSEcCtD
Vidarabine—Vomiting—Methazolamide—glaucoma	0.00092	0.00122	CcSEcCtD
Vidarabine—Anaphylactic shock—Dorzolamide—glaucoma	0.000918	0.00122	CcSEcCtD
Vidarabine—Hypertension—Pilocarpine—glaucoma	0.000917	0.00122	CcSEcCtD
Vidarabine—Rash—Methazolamide—glaucoma	0.000912	0.00121	CcSEcCtD
Vidarabine—Dermatitis—Methazolamide—glaucoma	0.000911	0.00121	CcSEcCtD
Vidarabine—Nausea—Carbachol—glaucoma	0.000911	0.00121	CcSEcCtD
Vidarabine—ADK—Metabolism—CTSA—glaucoma	0.000909	0.00383	CbGpPWpGaD
Vidarabine—Tinnitus—Clonidine—glaucoma	0.000909	0.00121	CcSEcCtD
Vidarabine—Sweating—Betaxolol—glaucoma	0.000906	0.00121	CcSEcCtD
Vidarabine—Headache—Methazolamide—glaucoma	0.000906	0.00121	CcSEcCtD
Vidarabine—Cardiac disorder—Clonidine—glaucoma	0.000905	0.0012	CcSEcCtD
Vidarabine—Chest pain—Pilocarpine—glaucoma	0.000905	0.0012	CcSEcCtD
Vidarabine—Shock—Dorzolamide—glaucoma	0.000903	0.0012	CcSEcCtD
Vidarabine—Anxiety—Pilocarpine—glaucoma	0.000901	0.0012	CcSEcCtD
Vidarabine—Paraesthesia—Acetazolamide—glaucoma	0.000899	0.0012	CcSEcCtD
Vidarabine—Hypotension—Brimonidine—glaucoma	0.000898	0.00119	CcSEcCtD
Vidarabine—Nausea—Levobunolol—glaucoma	0.000897	0.00119	CcSEcCtD
Vidarabine—Discomfort—Pilocarpine—glaucoma	0.000894	0.00119	CcSEcCtD
Vidarabine—Tachycardia—Travoprost—glaucoma	0.000892	0.00119	CcSEcCtD
Vidarabine—Somnolence—Acetazolamide—glaucoma	0.00089	0.00118	CcSEcCtD
Vidarabine—Hyperhidrosis—Dorzolamide—glaucoma	0.000887	0.00118	CcSEcCtD
Vidarabine—Rash—Latanoprost—glaucoma	0.000883	0.00117	CcSEcCtD
Vidarabine—Dermatitis—Latanoprost—glaucoma	0.000882	0.00117	CcSEcCtD
Vidarabine—Tachycardia—Brinzolamide—glaucoma	0.00088	0.00117	CcSEcCtD
Vidarabine—Mediastinal disorder—Clonidine—glaucoma	0.000878	0.00117	CcSEcCtD
Vidarabine—Headache—Latanoprost—glaucoma	0.000877	0.00117	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000875	0.00116	CcSEcCtD
Vidarabine—Arrhythmia—Clonidine—glaucoma	0.000871	0.00116	CcSEcCtD
Vidarabine—Bradycardia—Betaxolol—glaucoma	0.000864	0.00115	CcSEcCtD
Vidarabine—Paraesthesia—Brimonidine—glaucoma	0.000863	0.00115	CcSEcCtD
Vidarabine—Nausea—Methazolamide—glaucoma	0.000859	0.00114	CcSEcCtD
Vidarabine—ADK—Metabolism—CA2—glaucoma	0.000858	0.00362	CbGpPWpGaD
Vidarabine—Hypotension—Dorzolamide—glaucoma	0.000857	0.00114	CcSEcCtD
Vidarabine—Dyspnoea—Brimonidine—glaucoma	0.000857	0.00114	CcSEcCtD
Vidarabine—Somnolence—Brimonidine—glaucoma	0.000854	0.00114	CcSEcCtD
Vidarabine—Hypotension—Travoprost—glaucoma	0.000854	0.00114	CcSEcCtD
Vidarabine—Shock—Pilocarpine—glaucoma	0.000853	0.00113	CcSEcCtD
Vidarabine—Bronchospasm—Timolol—glaucoma	0.000852	0.00113	CcSEcCtD
Vidarabine—Tachycardia—Pilocarpine—glaucoma	0.000846	0.00113	CcSEcCtD
Vidarabine—Hypoaesthesia—Betaxolol—glaucoma	0.000844	0.00112	CcSEcCtD
Vidarabine—Hypotension—Brinzolamide—glaucoma	0.000843	0.00112	CcSEcCtD
Vidarabine—Hyperhidrosis—Pilocarpine—glaucoma	0.000838	0.00112	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000836	0.00111	CcSEcCtD
Vidarabine—Tension—Clonidine—glaucoma	0.000833	0.00111	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Travoprost—glaucoma	0.000832	0.00111	CcSEcCtD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—NTRK2—glaucoma	0.000828	0.00349	CbGpPWpGaD
Vidarabine—Hypersensitivity—Apraclonidine—glaucoma	0.000825	0.0011	CcSEcCtD
Vidarabine—Nervousness—Clonidine—glaucoma	0.000824	0.0011	CcSEcCtD
Vidarabine—Paraesthesia—Dorzolamide—glaucoma	0.000824	0.0011	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000822	0.00109	CcSEcCtD
Vidarabine—Pain—Brimonidine—glaucoma	0.000822	0.00109	CcSEcCtD
Vidarabine—Dyspnoea—Dorzolamide—glaucoma	0.000818	0.00109	CcSEcCtD
Vidarabine—Somnolence—Dorzolamide—glaucoma	0.000816	0.00109	CcSEcCtD
Vidarabine—Dyspnoea—Travoprost—glaucoma	0.000815	0.00108	CcSEcCtD
Vidarabine—Hypotension—Pilocarpine—glaucoma	0.00081	0.00108	CcSEcCtD
Vidarabine—Paraesthesia—Brinzolamide—glaucoma	0.00081	0.00108	CcSEcCtD
Vidarabine—Dyspnoea—Brinzolamide—glaucoma	0.000804	0.00107	CcSEcCtD
Vidarabine—Asthenia—Apraclonidine—glaucoma	0.000803	0.00107	CcSEcCtD
Vidarabine—Somnolence—Brinzolamide—glaucoma	0.000802	0.00107	CcSEcCtD
Vidarabine—Vision blurred—Clonidine—glaucoma	0.0008	0.00106	CcSEcCtD
Vidarabine—Urticaria—Acetazolamide—glaucoma	0.000795	0.00106	CcSEcCtD
Vidarabine—Tremor—Clonidine—glaucoma	0.000795	0.00106	CcSEcCtD
Vidarabine—Tinnitus—Betaxolol—glaucoma	0.000791	0.00105	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.00079	0.00105	CcSEcCtD
Vidarabine—Flushing—Betaxolol—glaucoma	0.000788	0.00105	CcSEcCtD
Vidarabine—Cardiac disorder—Betaxolol—glaucoma	0.000788	0.00105	CcSEcCtD
Vidarabine—Pain—Dorzolamide—glaucoma	0.000785	0.00104	CcSEcCtD
Vidarabine—Pain—Travoprost—glaucoma	0.000781	0.00104	CcSEcCtD
Vidarabine—Agitation—Clonidine—glaucoma	0.00078	0.00104	CcSEcCtD
Vidarabine—Paraesthesia—Pilocarpine—glaucoma	0.000779	0.00104	CcSEcCtD
Vidarabine—Asthenia—Bimatoprost—glaucoma	0.000779	0.00104	CcSEcCtD
Vidarabine—Angioedema—Clonidine—glaucoma	0.000775	0.00103	CcSEcCtD
Vidarabine—Dyspnoea—Pilocarpine—glaucoma	0.000773	0.00103	CcSEcCtD
Vidarabine—Pain—Brinzolamide—glaucoma	0.000771	0.00103	CcSEcCtD
Vidarabine—Somnolence—Pilocarpine—glaucoma	0.000771	0.00103	CcSEcCtD
Vidarabine—Mediastinal disorder—Betaxolol—glaucoma	0.000765	0.00102	CcSEcCtD
Vidarabine—Syncope—Clonidine—glaucoma	0.000761	0.00101	CcSEcCtD
Vidarabine—Arrhythmia—Betaxolol—glaucoma	0.000758	0.00101	CcSEcCtD
Vidarabine—Palpitations—Clonidine—glaucoma	0.00075	0.000997	CcSEcCtD
Vidarabine—Loss of consciousness—Clonidine—glaucoma	0.000746	0.000992	CcSEcCtD
Vidarabine—Pain—Pilocarpine—glaucoma	0.000741	0.000986	CcSEcCtD
Vidarabine—Cough—Clonidine—glaucoma	0.00074	0.000985	CcSEcCtD
Vidarabine—Sweating—Timolol—glaucoma	0.00074	0.000985	CcSEcCtD
Vidarabine—Dizziness—Apraclonidine—glaucoma	0.00074	0.000985	CcSEcCtD
Vidarabine—Urticaria—Dorzolamide—glaucoma	0.000729	0.00097	CcSEcCtD
Vidarabine—Tension—Betaxolol—glaucoma	0.000725	0.000964	CcSEcCtD
Vidarabine—ADORA2A—Circadian rythm related genes—NGFR—glaucoma	0.000725	0.00305	CbGpPWpGaD
Vidarabine—Dysgeusia—Betaxolol—glaucoma	0.000723	0.000962	CcSEcCtD
Vidarabine—Chest pain—Clonidine—glaucoma	0.000722	0.000961	CcSEcCtD
Vidarabine—Anxiety—Clonidine—glaucoma	0.00072	0.000958	CcSEcCtD
Vidarabine—Asthenia—Acetazolamide—glaucoma	0.000718	0.000956	CcSEcCtD
Vidarabine—Dizziness—Bimatoprost—glaucoma	0.000718	0.000955	CcSEcCtD
Vidarabine—Nervousness—Betaxolol—glaucoma	0.000717	0.000954	CcSEcCtD
Vidarabine—Urticaria—Brinzolamide—glaucoma	0.000717	0.000953	CcSEcCtD
Vidarabine—Discomfort—Clonidine—glaucoma	0.000714	0.000949	CcSEcCtD
Vidarabine—Vomiting—Apraclonidine—glaucoma	0.000712	0.000947	CcSEcCtD
Vidarabine—Hypersensitivity—Brimonidine—glaucoma	0.000708	0.000942	CcSEcCtD
Vidarabine—Dry mouth—Clonidine—glaucoma	0.000706	0.00094	CcSEcCtD
Vidarabine—Bradycardia—Timolol—glaucoma	0.000706	0.000939	CcSEcCtD
Vidarabine—DPP4—Metabolism of proteins—PAX6—glaucoma	0.000706	0.00297	CbGpPWpGaD
Vidarabine—Dermatitis—Apraclonidine—glaucoma	0.000705	0.000938	CcSEcCtD
Vidarabine—Headache—Apraclonidine—glaucoma	0.000701	0.000933	CcSEcCtD
Vidarabine—Vision blurred—Betaxolol—glaucoma	0.000696	0.000926	CcSEcCtD
Vidarabine—Tremor—Betaxolol—glaucoma	0.000692	0.000921	CcSEcCtD
Vidarabine—Asthenia—Brimonidine—glaucoma	0.000689	0.000917	CcSEcCtD
Vidarabine—ADORA2A—Circadian rythm related genes—NTRK1—glaucoma	0.000689	0.0029	CbGpPWpGaD
Vidarabine—Rash—Bimatoprost—glaucoma	0.000684	0.00091	CcSEcCtD
Vidarabine—Dermatitis—Bimatoprost—glaucoma	0.000684	0.000909	CcSEcCtD
Vidarabine—Shock—Clonidine—glaucoma	0.000681	0.000906	CcSEcCtD
Vidarabine—Headache—Bimatoprost—glaucoma	0.00068	0.000904	CcSEcCtD
Vidarabine—Hypersensitivity—Dorzolamide—glaucoma	0.000676	0.000899	CcSEcCtD
Vidarabine—Tachycardia—Clonidine—glaucoma	0.000676	0.000899	CcSEcCtD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—NTRK1—glaucoma	0.000675	0.00285	CbGpPWpGaD
Vidarabine—Hypersensitivity—Travoprost—glaucoma	0.000673	0.000896	CcSEcCtD
Vidarabine—Hyperhidrosis—Clonidine—glaucoma	0.000669	0.000891	CcSEcCtD
Vidarabine—Nausea—Apraclonidine—glaucoma	0.000665	0.000884	CcSEcCtD
Vidarabine—Hypersensitivity—Brinzolamide—glaucoma	0.000665	0.000884	CcSEcCtD
Vidarabine—Syncope—Betaxolol—glaucoma	0.000662	0.000881	CcSEcCtD
Vidarabine—Dizziness—Acetazolamide—glaucoma	0.000662	0.000881	CcSEcCtD
Vidarabine—Asthenia—Dorzolamide—glaucoma	0.000658	0.000876	CcSEcCtD
Vidarabine—Asthenia—Travoprost—glaucoma	0.000656	0.000872	CcSEcCtD
Vidarabine—Palpitations—Betaxolol—glaucoma	0.000653	0.000868	CcSEcCtD
Vidarabine—Loss of consciousness—Betaxolol—glaucoma	0.000649	0.000864	CcSEcCtD
Vidarabine—Asthenia—Brinzolamide—glaucoma	0.000647	0.000861	CcSEcCtD
Vidarabine—Hypotension—Clonidine—glaucoma	0.000647	0.000861	CcSEcCtD
Vidarabine—Tinnitus—Timolol—glaucoma	0.000646	0.00086	CcSEcCtD
Vidarabine—Cough—Betaxolol—glaucoma	0.000645	0.000857	CcSEcCtD
Vidarabine—Nausea—Bimatoprost—glaucoma	0.000645	0.000857	CcSEcCtD
Vidarabine—Cardiac disorder—Timolol—glaucoma	0.000643	0.000856	CcSEcCtD
Vidarabine—Hypersensitivity—Pilocarpine—glaucoma	0.000639	0.00085	CcSEcCtD
Vidarabine—ADA—Metabolism—CA1—glaucoma	0.000638	0.00269	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—NTRK2—glaucoma	0.000637	0.00269	CbGpPWpGaD
Vidarabine—Vomiting—Acetazolamide—glaucoma	0.000637	0.000847	CcSEcCtD
Vidarabine—Dizziness—Brimonidine—glaucoma	0.000635	0.000845	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Clonidine—glaucoma	0.000631	0.000839	CcSEcCtD
Vidarabine—Chest pain—Betaxolol—glaucoma	0.000629	0.000837	CcSEcCtD
Vidarabine—Headache—Acetazolamide—glaucoma	0.000627	0.000834	CcSEcCtD
Vidarabine—Anxiety—Betaxolol—glaucoma	0.000627	0.000834	CcSEcCtD
Vidarabine—Mediastinal disorder—Timolol—glaucoma	0.000625	0.000831	CcSEcCtD
Vidarabine—Asthenia—Pilocarpine—glaucoma	0.000622	0.000828	CcSEcCtD
Vidarabine—Paraesthesia—Clonidine—glaucoma	0.000622	0.000827	CcSEcCtD
Vidarabine—Discomfort—Betaxolol—glaucoma	0.000621	0.000827	CcSEcCtD
Vidarabine—Arrhythmia—Timolol—glaucoma	0.000619	0.000824	CcSEcCtD
Vidarabine—ADA—Metabolism—CTSA—glaucoma	0.000618	0.0026	CbGpPWpGaD
Vidarabine—Dyspnoea—Clonidine—glaucoma	0.000617	0.000821	CcSEcCtD
Vidarabine—Somnolence—Clonidine—glaucoma	0.000616	0.000819	CcSEcCtD
Vidarabine—Dry mouth—Betaxolol—glaucoma	0.000615	0.000818	CcSEcCtD
Vidarabine—ADORA2A—GPCR downstream signaling—OPN4—glaucoma	0.000614	0.00259	CbGpPWpGaD
Vidarabine—Dizziness—Dorzolamide—glaucoma	0.000607	0.000807	CcSEcCtD
Vidarabine—Rash—Brimonidine—glaucoma	0.000606	0.000806	CcSEcCtD
Vidarabine—Dermatitis—Brimonidine—glaucoma	0.000605	0.000805	CcSEcCtD
Vidarabine—ADK—Metabolism—TXN—glaucoma	0.000605	0.00255	CbGpPWpGaD
Vidarabine—Dizziness—Travoprost—glaucoma	0.000604	0.000804	CcSEcCtD
Vidarabine—Headache—Brimonidine—glaucoma	0.000602	0.000801	CcSEcCtD
Vidarabine—Dizziness—Brinzolamide—glaucoma	0.000597	0.000794	CcSEcCtD
Vidarabine—Nausea—Acetazolamide—glaucoma	0.000595	0.000791	CcSEcCtD
Vidarabine—Shock—Betaxolol—glaucoma	0.000593	0.000789	CcSEcCtD
Vidarabine—Tension—Timolol—glaucoma	0.000592	0.000788	CcSEcCtD
Vidarabine—Pain—Clonidine—glaucoma	0.000592	0.000788	CcSEcCtD
Vidarabine—Dysgeusia—Timolol—glaucoma	0.000591	0.000786	CcSEcCtD
Vidarabine—Tachycardia—Betaxolol—glaucoma	0.000588	0.000783	CcSEcCtD
Vidarabine—Nervousness—Timolol—glaucoma	0.000586	0.00078	CcSEcCtD
Vidarabine—Vomiting—Dorzolamide—glaucoma	0.000583	0.000776	CcSEcCtD
Vidarabine—ADA—Metabolism—CA2—glaucoma	0.000583	0.00246	CbGpPWpGaD
Vidarabine—Hyperhidrosis—Betaxolol—glaucoma	0.000583	0.000775	CcSEcCtD
Vidarabine—Rash—Dorzolamide—glaucoma	0.000579	0.00077	CcSEcCtD
Vidarabine—Dermatitis—Dorzolamide—glaucoma	0.000578	0.000769	CcSEcCtD
Vidarabine—Rash—Travoprost—glaucoma	0.000576	0.000766	CcSEcCtD
Vidarabine—Dermatitis—Travoprost—glaucoma	0.000576	0.000766	CcSEcCtD
Vidarabine—Headache—Dorzolamide—glaucoma	0.000575	0.000765	CcSEcCtD
Vidarabine—Vomiting—Brinzolamide—glaucoma	0.000574	0.000763	CcSEcCtD
Vidarabine—Dizziness—Pilocarpine—glaucoma	0.000573	0.000763	CcSEcCtD
Vidarabine—Headache—Travoprost—glaucoma	0.000572	0.000761	CcSEcCtD
Vidarabine—Nausea—Brimonidine—glaucoma	0.000571	0.000759	CcSEcCtD
Vidarabine—Rash—Brinzolamide—glaucoma	0.000569	0.000757	CcSEcCtD
Vidarabine—Vision blurred—Timolol—glaucoma	0.000569	0.000757	CcSEcCtD
Vidarabine—Dermatitis—Brinzolamide—glaucoma	0.000568	0.000756	CcSEcCtD
Vidarabine—Headache—Brinzolamide—glaucoma	0.000565	0.000752	CcSEcCtD
Vidarabine—Hypotension—Betaxolol—glaucoma	0.000563	0.000749	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—OPN4—glaucoma	0.000558	0.00235	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PTGFR—glaucoma	0.000553	0.00233	CbGpPWpGaD
Vidarabine—Angioedema—Timolol—glaucoma	0.000551	0.000734	CcSEcCtD
Vidarabine—Vomiting—Pilocarpine—glaucoma	0.000551	0.000733	CcSEcCtD
Vidarabine—Urticaria—Clonidine—glaucoma	0.00055	0.000732	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000549	0.000731	CcSEcCtD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—NGF—glaucoma	0.000549	0.00231	CbGpPWpGaD
Vidarabine—Rash—Pilocarpine—glaucoma	0.000547	0.000727	CcSEcCtD
Vidarabine—ADORA2A—Signaling by NGF—NGFR—glaucoma	0.000547	0.0023	CbGpPWpGaD
Vidarabine—Dermatitis—Pilocarpine—glaucoma	0.000546	0.000727	CcSEcCtD
Vidarabine—Nausea—Dorzolamide—glaucoma	0.000545	0.000725	CcSEcCtD
Vidarabine—Headache—Pilocarpine—glaucoma	0.000543	0.000723	CcSEcCtD
Vidarabine—Nausea—Travoprost—glaucoma	0.000543	0.000722	CcSEcCtD
Vidarabine—Paraesthesia—Betaxolol—glaucoma	0.000541	0.00072	CcSEcCtD
Vidarabine—Syncope—Timolol—glaucoma	0.000541	0.00072	CcSEcCtD
Vidarabine—ADORA2A—Circadian rythm related genes—FAS—glaucoma	0.00054	0.00227	CbGpPWpGaD
Vidarabine—Dyspnoea—Betaxolol—glaucoma	0.000537	0.000715	CcSEcCtD
Vidarabine—Nausea—Brinzolamide—glaucoma	0.000536	0.000713	CcSEcCtD
Vidarabine—Palpitations—Timolol—glaucoma	0.000533	0.000709	CcSEcCtD
Vidarabine—Loss of consciousness—Timolol—glaucoma	0.00053	0.000706	CcSEcCtD
Vidarabine—Cough—Timolol—glaucoma	0.000527	0.000701	CcSEcCtD
Vidarabine—Hypertension—Timolol—glaucoma	0.000521	0.000693	CcSEcCtD
Vidarabine—ADORA2A—Signaling by NGF—NTRK1—glaucoma	0.000519	0.00219	CbGpPWpGaD
Vidarabine—Pain—Betaxolol—glaucoma	0.000516	0.000686	CcSEcCtD
Vidarabine—Nausea—Pilocarpine—glaucoma	0.000515	0.000685	CcSEcCtD
Vidarabine—Chest pain—Timolol—glaucoma	0.000514	0.000683	CcSEcCtD
Vidarabine—Anxiety—Timolol—glaucoma	0.000512	0.000681	CcSEcCtD
Vidarabine—Hypersensitivity—Clonidine—glaucoma	0.00051	0.000679	CcSEcCtD
Vidarabine—Discomfort—Timolol—glaucoma	0.000508	0.000675	CcSEcCtD
Vidarabine—Dry mouth—Timolol—glaucoma	0.000502	0.000668	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—PTGFR—glaucoma	0.000502	0.00212	CbGpPWpGaD
Vidarabine—Asthenia—Clonidine—glaucoma	0.000497	0.000661	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—SMO—glaucoma	0.000493	0.00208	CbGpPWpGaD
Vidarabine—Anaphylactic shock—Timolol—glaucoma	0.000492	0.000655	CcSEcCtD
Vidarabine—Shock—Timolol—glaucoma	0.000485	0.000645	CcSEcCtD
Vidarabine—Urticaria—Betaxolol—glaucoma	0.000479	0.000637	CcSEcCtD
Vidarabine—Hyperhidrosis—Timolol—glaucoma	0.000476	0.000633	CcSEcCtD
Vidarabine—ADORA2A—Signaling Pathways—LRP12—glaucoma	0.000475	0.002	CbGpPWpGaD
Vidarabine—ADK—Metabolism—GSTT1—glaucoma	0.000469	0.00198	CbGpPWpGaD
Vidarabine—Hypotension—Timolol—glaucoma	0.00046	0.000612	CcSEcCtD
Vidarabine—Dizziness—Clonidine—glaucoma	0.000458	0.000609	CcSEcCtD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—BAD—glaucoma	0.000452	0.00191	CbGpPWpGaD
Vidarabine—Musculoskeletal discomfort—Timolol—glaucoma	0.000449	0.000597	CcSEcCtD
Vidarabine—Hypersensitivity—Betaxolol—glaucoma	0.000444	0.000591	CcSEcCtD
Vidarabine—Paraesthesia—Timolol—glaucoma	0.000442	0.000588	CcSEcCtD
Vidarabine—Vomiting—Clonidine—glaucoma	0.00044	0.000586	CcSEcCtD
Vidarabine—Dyspnoea—Timolol—glaucoma	0.000439	0.000584	CcSEcCtD
Vidarabine—Somnolence—Timolol—glaucoma	0.000438	0.000582	CcSEcCtD
Vidarabine—Rash—Clonidine—glaucoma	0.000437	0.000581	CcSEcCtD
Vidarabine—Dermatitis—Clonidine—glaucoma	0.000436	0.00058	CcSEcCtD
Vidarabine—Headache—Clonidine—glaucoma	0.000434	0.000577	CcSEcCtD
Vidarabine—Asthenia—Betaxolol—glaucoma	0.000433	0.000575	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000427	0.0018	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—NGF—glaucoma	0.000422	0.00178	CbGpPWpGaD
Vidarabine—Pain—Timolol—glaucoma	0.000421	0.00056	CcSEcCtD
Vidarabine—Nausea—Clonidine—glaucoma	0.000411	0.000547	CcSEcCtD
Vidarabine—ADA—Metabolism—TXN—glaucoma	0.000411	0.00173	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—MMP1—glaucoma	0.000402	0.00169	CbGpPWpGaD
Vidarabine—Dizziness—Betaxolol—glaucoma	0.000399	0.00053	CcSEcCtD
Vidarabine—Urticaria—Timolol—glaucoma	0.000391	0.00052	CcSEcCtD
Vidarabine—Vomiting—Betaxolol—glaucoma	0.000383	0.00051	CcSEcCtD
Vidarabine—Rash—Betaxolol—glaucoma	0.00038	0.000506	CcSEcCtD
Vidarabine—Dermatitis—Betaxolol—glaucoma	0.00038	0.000505	CcSEcCtD
Vidarabine—Headache—Betaxolol—glaucoma	0.000378	0.000502	CcSEcCtD
Vidarabine—ADK—Metabolism—ABCA1—glaucoma	0.000374	0.00157	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CYP1B1—glaucoma	0.000374	0.00157	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000373	0.00157	CbGpPWpGaD
Vidarabine—Hypersensitivity—Timolol—glaucoma	0.000363	0.000483	CcSEcCtD
Vidarabine—Nausea—Betaxolol—glaucoma	0.000358	0.000476	CcSEcCtD
Vidarabine—Asthenia—Timolol—glaucoma	0.000353	0.00047	CcSEcCtD
Vidarabine—ADA—Circadian rythm related genes—TP53—glaucoma	0.000352	0.00148	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—BAD—glaucoma	0.000348	0.00147	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—OPN4—glaucoma	0.000329	0.00139	CbGpPWpGaD
Vidarabine—Dizziness—Timolol—glaucoma	0.000326	0.000433	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—EDN1—glaucoma	0.000325	0.00137	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GSTT1—glaucoma	0.000319	0.00134	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—CDKN1B—glaucoma	0.000315	0.00133	CbGpPWpGaD
Vidarabine—Vomiting—Timolol—glaucoma	0.000313	0.000417	CcSEcCtD
Vidarabine—DPP4—Metabolism of proteins—MMP2—glaucoma	0.000311	0.00131	CbGpPWpGaD
Vidarabine—Rash—Timolol—glaucoma	0.000311	0.000413	CcSEcCtD
Vidarabine—Dermatitis—Timolol—glaucoma	0.00031	0.000413	CcSEcCtD
Vidarabine—Headache—Timolol—glaucoma	0.000309	0.00041	CcSEcCtD
Vidarabine—ADORA2A—Signaling Pathways—HEYL—glaucoma	0.000306	0.00129	CbGpPWpGaD
Vidarabine—ADK—Metabolism—GSTM1—glaucoma	0.000299	0.00126	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PTGFR—glaucoma	0.000297	0.00125	CbGpPWpGaD
Vidarabine—Nausea—Timolol—glaucoma	0.000293	0.000389	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—C3—glaucoma	0.000284	0.0012	CbGpPWpGaD
Vidarabine—ADK—Metabolism—MTHFR—glaucoma	0.000264	0.00111	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ABCA1—glaucoma	0.000254	0.00107	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CYP1B1—glaucoma	0.000254	0.00107	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—SMO—glaucoma	0.000253	0.00107	CbGpPWpGaD
Vidarabine—ADK—Metabolism—APOE—glaucoma	0.000246	0.00104	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CAV1—glaucoma	0.000243	0.00103	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—CDKN1B—glaucoma	0.000242	0.00102	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—RPTOR—glaucoma	0.000232	0.000979	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NCK2—glaucoma	0.000225	0.000948	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GSTM1—glaucoma	0.000203	0.000856	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—TP53—glaucoma	0.000202	0.000851	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HDAC9—glaucoma	0.000191	0.000806	CbGpPWpGaD
Vidarabine—ADK—Metabolism—NOS3—glaucoma	0.000184	0.000776	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—EDN1—glaucoma	0.000184	0.000775	CbGpPWpGaD
Vidarabine—ADA—Metabolism—MTHFR—glaucoma	0.000179	0.000756	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PTGS2—glaucoma	0.000168	0.00071	CbGpPWpGaD
Vidarabine—ADA—Metabolism—APOE—glaucoma	0.000167	0.000704	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—EDN1—glaucoma	0.000167	0.000704	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CAV1—glaucoma	0.000165	0.000698	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—C3—glaucoma	0.000161	0.000677	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SMO—glaucoma	0.00015	0.000631	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—C3—glaucoma	0.000146	0.000615	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NTRK2—glaucoma	0.000137	0.000577	CbGpPWpGaD
Vidarabine—ADA—Metabolism—NOS3—glaucoma	0.000125	0.000527	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NGFR—glaucoma	0.000117	0.000495	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PTGS2—glaucoma	0.000114	0.000482	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NTRK1—glaucoma	0.000112	0.00047	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CDKN2B—glaucoma	0.000103	0.000433	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—EDN1—glaucoma	9.86e-05	0.000416	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NGF—glaucoma	9.06e-05	0.000382	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—C3—glaucoma	8.62e-05	0.000363	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—APOE—glaucoma	8.02e-05	0.000338	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CAV1—glaucoma	7.95e-05	0.000335	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FN1—glaucoma	7.56e-05	0.000319	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—BAD—glaucoma	7.47e-05	0.000315	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NOS3—glaucoma	6.01e-05	0.000253	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CDKN1B—glaucoma	5.21e-05	0.000219	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MMP9—glaucoma	4.82e-05	0.000203	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—VEGFA—glaucoma	4.33e-05	0.000182	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TP53—glaucoma	3.27e-05	0.000138	CbGpPWpGaD
